Pillstats
Rx only · Tablet, Film Coated · Oral

Naloxegol Oxalate

Brands: Movantik · Naloxegol Oxalate

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US3 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1551777
US makers2 labelers
Packages12
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$4.20$8.41$12.61$16.82Dec 2025May 2026Jul 2026
$14.612
Latest avg · Jul 22, 2026
+5%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

8.6K17K26K35K2025 Q12025 Q22025 Q32025 Q42026 Q1
30K
Rx · 2026 Q1
882K
Units dispensed
+4%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Valinor Pharma, LLCunknown8SUPPLYING
RedHill Biopharma Ltdunknown4EXITED 2027

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.